Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To award a Congressional Gold Medal to Jerry Lewis in recognition of his outstanding service to the Nation.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
SMA Treatment Acceleration Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · fourth_quarter · Q4
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
SMA Treatment Acceleration Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2008
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2008
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
ALS Registry Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
ALS Registry Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
A bill to authorize Congress to award a gold medal to Jerry Lewis, in recognition of his outstanding service to the Nation.
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
H.R. 3035 and S. 1603, legislation to award the Congressional Gold Medal to Jerry Lewis.
SMA Treatment Acceleration Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
SMA Treatment Acceleration Act
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments Act of 2008
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments Act of 2008
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Medicaid Nursing Incentive Act of 2003
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Medicaid Nursing Incentive Act of 2003
Client: MUSCULAR DYSTROPHY ASSOCIATION, INC. · Firm: MUSCULAR DYSTROPHY ASSOCIATION, INC.
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
MUSCULAR DYSTROPHY ASSOCIATION, INC. via MUSCULAR DYSTROPHY ASSOCIATION, INC.
2008 · third_quarter · Q3
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE